Institutional investors launched an initiative Tuesday aimed at ensuring equitable global access to COVID-19 vaccines and other tools.
So far, 148 asset managers and owners with a collective $14 trillion in assets have signed on to a global investor statement in support of an effective, fair and equitable global response to COVID-19.
The investor statement calls on world leaders to finance the Access to COVID-19 Tools Accelerator, or ACT Acclerator, to ensure equitable access to COVID-19 tools.
Investors also pledge to work directly with the health-care companies in which they invest, urging them to pick up the pace of responding to the pandemic, including cross-industry partnerships for research and development, pricing and licensing agreements.